V

VectorY Therapeutics

HealthNeurodegenerative Diseases📍 Amsterdam, Netherlands

VectorY Therapeutics is focused on developing innovative therapies for ALS and other neurodegenerative diseases. The company aims to address significant unmet medical needs in this challenging area of healthcare. The recent funding will support their research and development efforts.

Total raised
Undisclosed
tracked to date
Latest round
€74.5 million
Nov 13, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Netherlands.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 Netherlands Funding Report

Read the Q4 2026 Netherlands report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-netherlands-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 Netherlands Funding Report</a>

Funding history

  1. 1
    €74.5 millionNov 13, 2026
    Announcement ↗

VectorY Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile

Startup | Datapile